Oklo (OKLO) Analyst Reiteration: Wedbush Maintains $150 Target on AI Nuclear Energy Prospects

This analysis is based on the analyst rating event reported on November 12, 2025, involving Wedbush Securities’ reiteration of Oklo’s (OKLO) Outperform rating with a $150 price target [1].

The Wedbush reiteration occurred during a period of significant market activity for Oklo, with the stock trading at $111.17 (+6.67%) on November 12, 2025, within a day range of $106.96 - $116.97 [0]. The stock demonstrated notable volatility, rising as much as 12.2% before settling at a 4.1% gain by mid-morning [4]. This analyst action follows the company’s Q3 2025 earnings release on November 11, which reported an EPS loss of $0.20, missing analyst estimates of $0.12 [4].

The bullish thesis from Wedbush centers on Oklo’s positioning at the intersection of two major trends: AI-driven data center energy demands and the nuclear renaissance through small modular reactors (SMRs). The firm specifically highlighted Oklo’s inclusion on the ‘IVES AI 30’ list as validation of its AI energy relevance [1]. William Blair’s concurrent Outperform reiteration emphasized progress in reactor development, including the Aurora and Pluto projects, along with VIPR technology advancement [1].

A significant regulatory milestone was achieved with the U.S. Department of Energy approving the Nuclear Safety Design Agreement for Oklo’s Aurora Fuel Fabrication Facility, representing a critical step toward commercial deployment [5]. This authorization provides a streamlined RD&D framework that could accelerate the path to commercial operation [5].

The analyst reiteration coincides with three converging developments: (1) regulatory approval from DOE, (2) strategic partnership with Battelle Energy Alliance for Idaho National Laboratory collaboration, and (3) growing market recognition of AI infrastructure energy demands [4][5]. This convergence creates a compelling narrative for Oklo’s future prospects.

The stock’s year-to-date performance of +408.79% reflects substantial market optimism despite the company’s pre-commercial status and negative earnings (EPS TTM: $-0.38) [0]. The current valuation metrics, including a P/E ratio of -292.55, indicate investors are pricing in significant future growth expectations rather than current fundamentals [0].

The Wedbush $150 target sits above the consensus target of $134.00 but within the broader analyst range of $75.00 - $175.00 [0]. Recent analyst actions show mixed sentiment: B. Riley Securities raised their target to $129 from $58, while Bank of America lowered theirs to $111 from $117, and Citigroup maintains a neutral stance with a $68 target [4].

Several factors warrant careful consideration. The company remains pre-commercial with no revenue generation expected until at least 2027, carrying significant execution risk [4]. While DOE authorization is positive, full commercial licensing with the Nuclear Regulatory Commission remains pending, creating regulatory uncertainty [5]. The stock’s substantial YTD gains and negative earnings create elevated valuation risk, particularly given the wide analyst target range indicating divergent views on fair value [0][4].

The growing power requirements for AI data centers present a significant market opportunity, with Oklo’s nuclear solutions positioned as clean baseload power options [1]. The DOE pilot program and streamlined RD&D framework could accelerate commercial deployment timelines [5]. Additional strategic partnerships and customer agreements beyond current MOUs could further validate the business model and provide revenue visibility.

The stock has shown momentum trading characteristics, including attention from Reddit WallStreetBets and high volatility with wide intraday swings [6]. This creates both opportunity and risk, as sentiment-driven price movements may disconnect from fundamental developments.

Oklo (OKLO) maintains a market capitalization of $16.41B with current analyst consensus at BUY (57.1% Buy, 42.9% Hold) and an average target price of $134.00 [0]. The company’s strategic positioning focuses on addressing AI infrastructure energy demands through small modular nuclear reactors, with the Aurora project representing the primary commercial pathway [1][5]. Recent regulatory milestones, including DOE authorization for the Fuel Fabrication Facility, provide important progress toward commercial deployment, though full NRC licensing remains pending [5]. The company’s financial profile reflects its pre-commercial stage, with negative earnings through at least 2028 analyst projections, but substantial market optimism about future prospects as evidenced by the 408% year-to-date stock performance [0][4].